Incubator/Accelerator

Blaze Systems is a provider of total LIMS software solutions for the laboratory marketplace.

Blaze Systems

Delaware Technology Park

CMC Biologics, fka CMC Biopharmaceuticals, is a global contract process development and manufacturer of monoclonal antibodies, coagulation factors, and other therapeutic proteins. The Company has expertise in delivering custom solutions for the scale-up and cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. CMC Biologics' wide range of integrated services includes cell line development, bioprocess development, formulation, and comprehensive analytical testing. Clients can also benefit from CMC Biologics' proprietary CHEF1 Expression System for mammalian production.

River Vision Development Corp. specializes in the development of teprotumumab, a therapy for an eye condition called Graves' ophthalmopathy.

Dave Madden

President and CEO

" - https://www.reportlinker.com/p06466645/?utm_source=GNW
, Eppendorf AG, Corning Corporation, Ferner PLC, Ashai Kasei Corporation, and Finesse Solutions Inc. The global downstream processing market is expected to grow from $23.72 billion in 2022 to $27.19 billion in 2023 at a compound annual growth rate (CAGR) of 14.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The downstream processing market is expected to reach $45.13 billion in 2027 at a CAGR of 13.5%. The downstream processing market consists of revenues earned by entities by providing downstream processing services such as cell separation, filtration, product recovery, extraction of products, and more.The market value includes the value of related goods sold by the service provider or included within the service offering. The Downstream processing market also includes sales of small-scale fermenters, pilot-scale fermenters, centrifuges, and membrane filtration systems which are used in providing downstream processing services.Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. Downstream processing refers to the recovery and purification of a drug substance (DS) from natural sources, such as animal or bacterial cells. It outlines the sequence of steps necessary to create a pure and homogenous protein product from biological components such as cells, tissue culture fluid, or plant tissues. North America was the largest region in the downstream processing market in 2022.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the downstream processing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The main types of products used in downstream processing are centrifuges, dryers, chromatography systems, filters, evaporators, and others, with various types of techniques involved, including purification techniques, solid-liquid separation, and clarification or concentration.Centrifuges refer to a device that uses centrifugal force to separate materials with different densities, remove moisture, or simulate the effects of gravity. It is used in several applications, such as monoclonal antibody production, vaccine production, insulin production, immunoglobulin production, erythropoietin production, and others. The increasing healthcare expenditure is expected to propel the growth of the downstream processing market going forward.Healthcare expenditure refers to all expenditures for the provision of health services, family planning activities, nutrition activities, and emergency aid designated for health. Downstream processing.Increasing expenditure would boost the sales of downstream processing as it helps in the extraction of a drug substance (DS) from natural sources, such as bacterial or animal cells, and the subsequent purification of the drug substance. For instance, in March 2022, according to the 2021–2030 National Health Expenditure (NHE) report published by the Centers for Medicare & Medicaid Services, a US-based Department of Health and Human Services department, the annual increase in national health spending was predicted to average 5.1% between 2021 and 2030, reaching approximately $6.8 trillion by 2030. Additionally, throughout the period 2021–2030, Medicare expenditures are expected to expand at a 7.2% annual rate, while Medicaid spending is expected to grow at a 5.6% annual rate. Therefore, the increasing healthcare expenditure is driving the growth of the downstream processing market. Product innovations are the key trends gaining popularity in the downstream processing market.Major companies operating in the downstream processing market are focused on developing new technological solutions to strengthen their position in the market. For instance, in September 2022, Tosoh Bioscience LLC, a US-based global chemical and specialty materials company, launched the Octave BIO Multi-Column Chromatography (MCC) system, a holistic multi-column chromatography solution for downstream process intensification.It is an advanced multi-column chromatography system for process development and proof of concept that was specifically created for the intensification of biomolecule purification processes. Wide-ranging requirements can be accommodated by the special modular design, which also makes it possible to take advantage of MCC’s resin and buffer cost savings and other real advantages. In January 2023, Astea Bio separations, a UK-based provider of bio separation and purification technologies, acquired Delta Precision Ltd. for an undisclosed amount. This acquisition will enable Astea Bio separations to strengthen and supplement its current portfolio of bioprocessing resins, reusable columns, and prepacked single-use columns by adding a broad range of high-performance chromatography columns for biomanufacturing. Delta Precision Ltd. is a UK-based manufacturer of advanced chromatography columns, and it produces products for various applications, including protein purification, vaccine production, and drug development. The countries covered in the downstream processing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The downstream processing market research report is one of a series of new reports that provides downstream processing market statistics, including downstream processing industry global market size, regional shares, competitors with a downstream processing market share, detailed downstream processing market segments, market trends and opportunities, and any further data you may need to thrive in the downstream processing industry. This downstream processing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Downstream Processing Global Market Report 2023

Adroit Market Research launched a report on “Global Bioreactors Market Trends for Non-food Applications, Segmentation By Product (Single-use, Multi-use), By Construction Material (Stainless Steel, Glass, Others), By Application (Biotechnology & Pharmaceutical, Contract Research Organizations (CROs), Others), By Region And Forecast From 2019 to 2025”. Request a Premium Sample of this Report at: https://www.adroitmarketresearch.com/contacts/request-sample/710
Global bioreactors market size is estimated to expand at nearly 16.0 % CAGR from 2019 to 2025. Asia Pacific is likely to showcase lucrative bioreactors market trends by 2025. The consumption of biopharmaceutical products is expected to showcase a prominent increase in the region over the next few years. As a result, the processes used for manufacturing these products are required to meet the market demand. The global bioreactors market size and forecast estimates have been provided in terms of revenue (USD million) in the recently published report. The qualitative and quantitative bioreactors market trends have been provided from 2012 to 2025, wherein 2012 to 2017 represents historic data. Product, construction material and application breakdown of the global bioreactors market size is given for the regional as well as country level. The report further includes bioreactor market shares of each of the segments mentioned above, for 2017 and 2025 respectively. Over the recent years, a significant increase of the foreign investments in the Asia Pacific biopharma sector has been witnessed. Owing to rising development costs, lower earnings, and requirement for talent specializing in the biotech sector, these companies have strong hopes towards Asia. The region has a broad pharmaceutical production base, lower manufacturing costs and paced up clinical development operations. As a consequence, this is expected to boost the bioreactor market share of Asia Pacific by 2025. Examine Report Description with Detailed ToC on Bioreactors Market at: https://www.adroitmarketresearch.com/industry-reports/bioreactors-market
The single use bioreactor market is expected to grow at more than 20% CAGR during the forecast period. The single Use bioreactor technology is extensively utilized in the field of biotechnology, since its incorporation ten years ago. A single-use bioreactor has multiple applications that range from academia to commercial sectors including research & development laboratories for drug discovery environmental, pharmaceutical, and life sciences. Single-use bioreactors are extensively used in CROs. CROs typically handle different products on account of which it is economical to use disposable bags in place of a stainless-steel vessel. The growing number of CROs is expected to augment the growth of the single use bioreactor market industry over the next few years. North America is considered to be the largest and fastest-growing consumers of the product and has contributed in increasing the global bioreactors market size, over the recent years. The increase in healthcare expenditure, focus on R&D for new drug development, and rising demand for drugs that treat HIV/AIDS, and cancer is expected to augment the product demand in the region, thus supporting the recent bioreactors market trends especially in the U.S. and Canada. Sartorius AG, Merck KGaA, and Thermo Fisher Scientific, Inc. captured over 40% of the global bioreactors market size in 2017. Multi-parallel bioreactors and single-use bioreactors are a few of the products offered by these players in the global market. Key segments of the global bioreactors market trends for non-food applications:
Product Overview, 2012-2025 (USD Million)
Single-use
Stainless steel
Biotechnology & pharmaceutical
North America
6.2 Biotechnology & pharmaceutical
6.4 Others
What does the report include? The study on the global bioreactors market includes qualitative market dynamics such as drivers, restraints, and opportunities
Additionally, the market has been evaluated using the value chain, PESTEL analysis and Porter’s Five Forces analysis
The study includes qualitative and quantitative analysis of the market categorized on the basis of product type, construction material, application and region
Actual market sizes and forecast figures have been provided for all the afore-mentioned market segments
About Adroit Market Research:
Adroit Market Research provide quantified B2B research on numerous opportunistic markets, and offer customized research reports, consulting services, and syndicate research reports. We assist our clients to strategize business decisions and attain sustainable growth in their respective domain. Additionally, we support them with their revenue planning, marketing strategies, and assist them to make decisions before the competition so that they remain ahead of the curve.

Bioreactors Market 2019 Manufacturers Profiles/Analysis, Characteristics, Key Factors, New Entrants SWOT Analysis till 2025 | Finesse Solutions, Applikon Biotechnology B.V., PBS Biotech, Danaher Corporation

Sekhmet Ventures , a Portola Valley, Calif.-based newly-formed venture capital firm in the beauty and wellness market, has appointed Sara Kaur as its Chief Financial Officer (CFO). Prior to Sekhmet, Ms. Kaur served as CFO of Finesse Solutions for three years, where she helped Finesse expand its operations and launch critical new ventures in the Asia-Pacific region. She has previously worked in the venture capital industry for Hercules Technology in Palo Alto, California where she was instrumental in achieving first-year compliance efforts for Sarbanes-Oxley. Ms. Kaur has also held positions as Finance Director and International Controller at Kulicke & Soffa Pte., Singapore and Director, SEC Reporting & Compliance at Ameresco Boston. She began her career in the UK at Honeywell as a Regional Controller and then moved to Silicon Valley, where her work experience includes Google, Actel Corporation (acquired by Microsemi) and Varian, Inc. (acquired by Agilent). Led by Barbara Paldus, Founding Partner, Sekhmet Ventures is a venture capital firm that invests worldwide in science-based companies addressing the clean beauty and wellness market. It provides its portfolio companies with capital, support to build a sales infrastructure and expertise in manufacturing and regulatory compliance. FinSMEs

Sekhmet Ventures Appoints Sara Kaur as CFO

staff reporter
NEW YORK (GenomeWeb) – Thermo Fisher Scientific disclosed in a filing yesterday with the US Securities and Exchange Commission the purchase price for its recent acquisitions of Core Informatics and Finesse Solutions, as well as the settlement earlier this year of three patent lawsuits involving DNA sequencing technology from Roche 454 Life Sciences and Illumina. Get the full story

Thermo Fisher Spent $314 on Two Acquisitions in Q1; Settled IP Suits With Roche 454, Illumina

Thermo Fisher Scientific Completes Acquisition of Finesse Solutions,      Inc.
February 14, 2017 06:15 PM Eastern Standard Time
WALTHAM, Mass.--( BUSINESS WIRE )--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving      science, today completed its previously announced acquisition of Finesse      Solutions, Inc. , a leader in the development of scalable control      automation systems and software for bioproduction. The business will be      integrated into Thermo Fisher’s Life Sciences Solutions Segment. Terms      of the transaction were not disclosed. Based in Santa Clara, California, Finesse Solutions is a leader in      bioprocess management technology, generating approximately $50 million      in revenue in 2016. Its proprietary Smart™ technology, which consists of      sensors, controllers and software, is designed to optimize the      bioproduction workflow. The company has been a technology partner of      Thermo Fisher Scientific since 2013. About Thermo Fisher Scientific
Thermo Fisher Scientific      Inc. (NYSE: TMO) is the world leader in serving science, with revenues      of $18 billion and more than 55,000 employees globally. Our mission is      to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex      analytical challenges, improve patient diagnostics and increase      laboratory productivity. Through our premier brands – Thermo Scientific,      Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services      – we offer an unmatched combination of innovative technologies,      purchasing convenience and comprehensive support. For more information,      please visit www.thermofisher.com . Contacts

Thermo Fisher Scientific Completes Acquisition of Finesse Solutions, Inc.

One Hill Solutions is a software development company which focuses on all aspects of data management visualization and analysis along with OSI-PI integration, start-up support and commissioning.

One Hill Solutions

SANTA CLARA , Calif. , June 21 , 2016 / PRNewswire / -- Finesse Solutions , Inc. , a manufacturer of measurement and control solutions for life sciences process applications , in partnership with One Hill Solutions , an innovative software developer in Massachusetts , announced the launch of the SmartLab platform for lab-scale bioprocess optimization .

Finesse and One Hill Solutions Release SmartLab(TM) Platform for Lab-Scale Bioprocess Optimization

Corning (NYSE: GLW) is a provider in specialty glass and ceramics. Drawing on more than 160 years of materials science and process engineering knowledge, Corning creates and makes keystone components that enable high-technology systems for consumer electronics, mobile emissions control, telecommunications and life sciences.

Corning

Alvotech (NASDAQ: ALVO) is a global biopharmaceutical company that develops biosimilar versions of leading monoclonal antibody molecules. It aims at transforming patients’ lives by improving access to affordable biosimilar medicines and enhancing the sustainability of healthcare systems. Alvotech currently has seven products in its pipeline across multiple therapeutic areas. Alvotech’s pipeline addresses originator products treating a diverse set of conditions across autoimmunity, ophthalmology, osteoporosis, and oncology. It was founded in 2013 and is based in Reykjavik, Iceland.

Alvotech

Spectra Automation is a consulting and systems integration provider offering solutions to companies operating in the areas of science, power and utilities, manufacturing, water, and waste water.

Spectra Automation

ATMI provides specialty semiconductor materials, materials development science, and high-purity materials handling and delivery solutions designed to increase process efficiencies for the semiconductor, flat panel and life sciences industries. ATMI Life Sciences is a provider in single-use technologies, products and systems for mixing, storage, bioreactors, cell culture technology, fluoropolymer-based products, and custom-engineered, flexible packaging solutions. The company's clean room manufacturing experience, combined with its fundamental knowledge of bioproduction - especially within cell culture - help drive development of specific single-use technologies that are well-adapted to process operations.

ATMI

Finesse Solutions

Acquired

Finesse was founded to bring digital, plug-and-play solutions to life science customers, so as to improve the management of complex bio-process applications. The company's initial focus is on improving sensor, hardware, and software solutions for process control in the biotechnology and pharmaceutical industries.

Thermo Fisher Scientific

LS9, the Renewable Petroleum Company, is a privately-held industrial biotechnology company pursuing the commercial development of renewable fuels and chemicals. LS9 is applying synthetic biology to produce proprietary biofuels that are compatible with existing fuel distribution and consumer infrastructure, as well as high-value industrial chemicals. LS9 is the pioneer in the commercial development of fermentation derived hydrocarbon biofuels and its patent-pending Renewable Petroleum products are custom engineered in the lab to address immediate market needs for clean energy alternatives to petroleum.

P&G serves consumers around the world with a portfolio of brands, including Always, Ambi Pur, Ariel, Bounty, Charmin, Crest, Dawn, Downy, Fairy, Febreze, Gain, Gillette, Head & Shoulders, Lenor, Olay, Oral-B, Pampers, Pantene, SK-II, Tide, Vicks, and Whisper. The P&G community includes operations in countries worldwide.

Wells Fargo Success Story

Professional Services

Platform Overview

Compare Blaze Systems vs Finesse Solutions

Customers evaluate the quality of Blaze Systems's products using the following success metrics.